Adding Zika Virus to the FDA Priority Review Voucher Program Act
Latest action · Apr 19, 2016 Became Public Law No: 114-146.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 8, 2016
- Passed SenateMar 17, 2016
- Passed HouseApr 12, 2016
- To the PresidentApr 14, 2016
- Became lawApr 19, 2016Public Law 114-146
Summary
(This measure has not been amended since it was reported to the Senate on March 15, 2016. The summary of that version is repeated here.)
Adding Zika Virus to the FDA Priority Review Voucher Program Act
(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to add Zika virus disease to the list of tropical diseases under the priority review voucher program, which awards a voucher to the sponsor of a new drug or biological product that is approved to prevent or treat a tropical disease. (A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.)
The bill makes a technical correction to the tropical disease list to refer to filovirus disease, a condition caused by the family of viruses that includes the Ebola virus, instead of the family of viruses.
Cosponsors 11
Members who signed on, in the order they did. Signatures ran from Feb 8, 2016 to Mar 15, 2016; 3 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-FL | Bill Nelson | Original | Feb 8, 2016 |
| R-GA | Johnny Isakson | Original | Feb 8, 2016 |
| D-OH | Sherrod Brown | Original | Feb 8, 2016 |
| R-IL | Mark Kirk | Feb 10, 2016 | |
| D-NJ | Robert Menendez | Feb 10, 2016 | |
| R-OH | Rob Portman | Feb 24, 2016 | |
| D-PA | Robert P. Casey Jr. | Feb 24, 2016 | |
| D-MN | Amy Klobuchar | Mar 10, 2016 | |
| D-CT | Christopher Murphy | Mar 10, 2016 | |
| D-WA | Patty Murray | Mar 10, 2016 | |
| R-TN | Lamar Alexander | Mar 15, 2016 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Health, Education, Labor, and Pensions Committee | Referred Feb 8, 2016Markup Mar 9, 2016Reported Mar 15, 2016 |
| House | Energy and Commerce Committee | Referred Mar 21, 2016 |
| Health Subcommittee | Referred Mar 25, 2016 |
Actions 18
Everything that happened, newest first.
- Apr 19, 2016Signed by President.
- Apr 19, 2016Became Public Law No: 114-146.
- Apr 14, 2016Presented to President.
- Apr 12, 2016Mrs. Brooks (IN) moved to suspend the rules and pass the bill.
- Apr 12, 2016Considered under suspension of the rules. (consideration: CR H1602-1605)
- Apr 12, 2016DEBATE - The House proceeded with forty minutes of debate on S. 2512.
- Apr 12, 2016Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H1602)
- Apr 12, 2016Motion to reconsider laid on the table Agreed to without objection.
- Mar 25, 2016Referred to the Subcommittee on Health.
- Mar 21, 2016Received in the House.
- Mar 21, 2016Referred to the House Committee on Energy and Commerce.
- Mar 18, 2016Message on Senate action sent to the House.
- Mar 17, 2016Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent. (consideration: CR S1606-1607; text as passed Senate: CR S1606)
- Mar 15, 2016Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
- Mar 15, 2016Placed on Senate Legislative Calendar under General Orders. Calendar No. 389.
- Mar 9, 2016Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
- Feb 8, 2016Introduced in Senate
- Feb 8, 2016Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
In the Congressional Record 6
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S2806 | Rob Portman R-OH | May 16, 2016 |
| Extensions | Debate and remarks E499 | Frank Pallone, Jr. D-NJ | Apr 18, 2016 |
| House | Debate and remarks H1602–H1605Text printed H1602 | Earl L. "Buddy" Carter R-GA, G. K. Butterfield D-NC, Gene Green D-TX, Sheila Jackson Lee D-TX, Susan W. Brooks R-IN | Apr 12, 2016 |
| Senate | Debate and remarks S1845 | Bill Nelson D-FL | Apr 11, 2016 |
| Senate | Debate and remarks S1606Text printed S1606Amendments S1606 | Mitch McConnell R-KY | Mar 17, 2016 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| S. Hrg. 114-534 | PRESIDENT'S FISCAL YEAR 2017 HEALTH CARE PROPOSALS119 pages | Finance Committee | Feb 11, 2016 |
CRS reports 5
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 5
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R45577 | Strategic Petroleum Reserve: Mandated Sales and Reform Archived | Report | Oct 1, 2019 |
| R44817 | U.S.-UK Free Trade Agreement: Prospects and Issues for Congress Archived | Report | Sep 5, 2017 |
| R44720 | The 21st Century Cures Act (Division A of P.L. 114-255) Archived | Report | Dec 23, 2016 |
| R44559 | Economic Implications of a United Kingdom Exit from the European Union Archived | Report | Jul 14, 2016 |
| R44545 | Zika Virus in Latin America and the Caribbean: U.S. Policy Considerations Archived | Report | Jun 30, 2016 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 4400 | Adding Zika Virus to the FDA Priority Review Voucher Program Act | Identical bill | Feb 5, 2016 |
Titles 6
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to expand the tropical disease product priority review voucher program to encourage treatments for Zika virus.
- Short Titles as Introduced
- Adding Zika Virus to the FDA Priority Review Voucher Program Act
- Short Titles as Reported to Senate
- Adding Zika Virus to the FDA Priority Review Voucher Program Act
- Short Titles as Passed House
- Adding Zika Virus to the FDA Priority Review Voucher Program Act
- Short Titles as Passed Senate
- Adding Zika Virus to the FDA Priority Review Voucher Program Act
- Short Titles as Enacted
- Adding Zika Virus to the FDA Priority Review Voucher Program Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 5
Each version as it was printed, newest first.
- —Enrolled Bill
- Mar 21, 2016Referred in House
- Mar 17, 2016Engrossed in Senate
- Mar 15, 2016Reported to Senate
- Feb 8, 2016Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
